Filing Flows › Elevance Health (ELV) › Guidance history
Elevance Health (ELV) guidance history: what it guided and what it reported
Elevance Health gave guidance in 12 earnings releases on file since Jan 24, 2024. Of 3 guided periods since reported, it met or beat its own guidance twice (67%). Revenue: 2 of 2, on average +25.8% against the guided midpoint. Its releases raised guidance 4 times and lowered it 0 times.
Revenue
Met or beat 2 of 2 periods (2 above, 0 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $167.1B (Jan 28, 2026) | — | to be reported | — |
| FY2025 | $150.3B (Jan 23, 2025) | $199.1B | above the range | +32.5% |
| FY2024 | $148.6B (Jan 24, 2024) | $177.0B | above the range | +19.1% |
GAAP operating margin
Met or beat 0 of 1 periods (0 above, 0 within, 1 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 2.5% (Jan 28, 2026) | — | to be reported | — |
| FY2025 | 4.2% (Jan 23, 2025) | 3.6% | below the range | -0.6 pts |
Operating margin
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2024 | 4.6% (Jan 24, 2024) | — | — | — |
Adjusted tax rate
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 22.0%–24.0% (Jan 28, 2026) | — | to be reported | — |
| FY2025 | 22.0%–24.0% (Jan 23, 2025) | — | — | — |
| FY2024 | 22.0%–24.0% (Jan 24, 2024) | — | — | — |
Interest expense
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2024 | $350M (Jan 24, 2024) | — | — | — |
Operating cash flow
The GAAP figure from the filings is shown for each period reported; it is not judged against the guide, which may leave items out (one-off payments, acquisitions).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $6.0B (Jul 15, 2026) → raised $6.5B (Oct 21, 2026) | — | to be reported | — |
| FY2024 | $8.1B (Jan 24, 2024) | $5.8B (GAAP) | not judged | — |
The latest quarter
Elevance Health, Q3 2026: revenue $51.4B (+1% year over year), operating margin 2.5%, net earnings $1.3B, operating cash flow $1.3B. The chart follows the revenue to costs, profit and cash.
Questions
Does Elevance Health beat its guidance?
Elevance Health gave guidance in 12 earnings releases on file since Jan 24, 2024. Of 3 guided periods since reported, it met or beat its own guidance twice (67%). Revenue: 2 of 2, on average +25.8% against the guided midpoint.
How often does Elevance Health raise guidance?
Its earnings releases raised guidance 4 times and lowered it 0 times since Jan 24, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.